+33 1 76 70 47 90
/
creativ@creativ-ceutical.com
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Home
Who We Are
About Us
Strategic Management Board
What we do
Value & Market Access
Payer Landscape
Pricing Research
Early Dialog
PRMA Strategy
Evidence Generation
Decision Sciences & Outcomes Research
Modeling
HTA submission
Data Analytics
Evidence Synthesis
Patient-Centered Research
Real World Evidence
Exclusive Customized Consulting
Biotech Strategic Consulting
Corporate Strategic Consulting
Expertise
Senior Management
Partnerships
Japan
Publications
News & Events
Careers
Contact
Cost-Effectiveness of Memantine in the treatment of Moderate to Severe Alzheimer’s Disease in Spain
Home
Publications
Cost-Effectiveness of Memantine in the treatment of Moderate to Severe Alzheimer’s Disease in Spain
Back Home
Cost-Effectiveness of Memantine in the treatment of Moderate to Severe Alzheimer’s Disease in Spain
2003 ISPOR Europe
Antonanzas-Villar, F. | Badenas, J. | Francois, C. | Guilhaume, C. |
Volume: , Issue: , Pages: ,
The website uses cookies.
Learn More
Ok
